A detailed history of Goldman Sachs Group Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 3,214,177 shares of EW stock, worth $218 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,214,177
Previous 4,004,371 19.73%
Holding current value
$218 Million
Previous $370 Million 42.66%
% of portfolio
0.04%
Previous 0.06%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$59.7 - $93.78 $47.2 Million - $74.1 Million
-790,194 Reduced 19.73%
3,214,177 $212 Million
Q2 2024

Aug 13, 2024

BUY
$84.3 - $94.31 $42.5 Million - $47.5 Million
504,177 Added 14.4%
4,004,371 $370 Million
Q1 2024

May 15, 2024

SELL
$72.54 - $95.56 $939,465 - $1.24 Million
-12,951 Reduced 0.37%
3,500,194 $334 Million
Q4 2023

Feb 13, 2024

BUY
$61.71 - $77.76 $3.23 Million - $4.07 Million
52,282 Added 1.51%
3,513,145 $268 Million
Q3 2023

May 14, 2024

SELL
$69.28 - $93.38 $3.62 Million - $4.88 Million
-52,282 Reduced 1.49%
3,460,863 $240 Million
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $87.2 Million - $117 Million
-1,257,981 Reduced 26.66%
3,460,863 $240 Million
Q2 2023

May 14, 2024

SELL
$81.41 - $94.33 $1.37 Million - $1.59 Million
-16,818 Reduced 0.36%
4,718,844 $445 Million
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $1.37 Million - $1.59 Million
-16,818 Reduced 0.36%
4,718,844 $445 Million
Q1 2023

May 14, 2024

BUY
$74.26 - $84.51 $97.2 Million - $111 Million
1,308,749 Added 38.19%
4,735,662 $392 Million
Q1 2023

May 11, 2023

BUY
$74.26 - $84.51 $97.2 Million - $111 Million
1,308,749 Added 38.19%
4,735,662 $392 Million
Q4 2022

May 14, 2024

BUY
$68.3 - $87.44 $11.4 Million - $14.6 Million
166,698 Added 5.11%
3,426,913 $256 Million
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $11.4 Million - $14.6 Million
166,698 Added 5.11%
3,426,913 $256 Million
Q3 2022

May 14, 2024

BUY
$82.37 - $107.29 $20.6 Million - $26.8 Million
249,875 Added 8.3%
3,260,215 $269 Million
Q3 2022

Nov 10, 2022

BUY
$82.37 - $107.29 $20.6 Million - $26.8 Million
249,875 Added 8.3%
3,260,215 $269 Million
Q2 2022

May 14, 2024

SELL
$86.5 - $128.27 $43.5 Million - $64.5 Million
-502,805 Reduced 14.31%
3,010,340 $286 Million
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $43.8 Million - $65 Million
506,630 Added 20.24%
3,010,340 $286 Million
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $31.2 Million - $39.2 Million
-305,591 Reduced 10.88%
2,503,710 $295 Million
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $4.12 Million - $5.06 Million
38,704 Added 1.4%
2,809,301 $364 Million
Q3 2021

Nov 10, 2021

BUY
$102.91 - $122.75 $285 Million - $340 Million
2,770,597 New
2,770,597 $314 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.